Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The Contemporary Management of Colorectal Cancer
1
x
$
30.00
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
1
x
$
0.00
Claus Rosenberg, MD: Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice
1
x
$
30.00
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 1, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Functional Assessment Staging (FAST)
1
x
$
0.00
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Cannabis Pen-Induced Psychosis in a First-Time Adolescent User
1
x
$
30.00
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder
1
x
$
30.00
Letter From the Editors: A Standing Ovation for a Change in How We Treat Patients With Cancer —Forever
1
x
$
0.00
Michael S. Clark, MD, PhD: The 5-HT1B Receptor: Behavioral Implications
1
x
$
30.00
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
1
x
$
30.00
Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report
1
x
$
30.00
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
1
x
$
30.00
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
1
x
$
0.00
Great Expectations in Stereochemistry: Focus on Antidepressants
1
x
$
0.00
New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report
1
x
$
30.00
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
1
x
$
30.00
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
1
x
$
0.00
Mechanism of Action of Antidepressants
1
x
$
30.00
Pharmacy Practice: Monitoring Chemotherapy in an Aging Population
1
x
$
0.00
View Cart
Checkout
Home
Store
“Pharmacy Practice: Monitoring Chemotherapy in an Aging Population” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
$
30.00
Add to cart
Details
Neurociencias: Estudios poblacionales de la relación entre el traumatismo craneoencefálico y la psiquiatría
$
0.00
Add to cart
Details
Neurociencias: Tipos de convulsiones, síndromes epilépticos, etiología y diagnóstico
$
0.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
$
30.00
Add to cart
Details
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
30.00
Add to cart
Details
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
$
30.00
Add to cart
Details
New Advances in the Management of Anxiety Disorders
$
30.00
Add to cart
Details
New Developments in Depression and Anxiety Disorders
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
New Single-Isomer Compounds on the Horizon
$
0.00
Add to cart
Details
New Strategies for the Treatment of Indolent Non-Hodgkin’s Lymphomas
$
0.00
Add to cart
Details
New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report
$
30.00
Add to cart
Details
New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/ Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report
$
30.00
Add to cart
Details
NEWLY UPDATED — Psychotropic Dosing and Monitoring: Children and Adolescents – Digital PDF
$
30.00
Add to cart
Details
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
$
30.00
Add to cart
Details
Previous
1
…
24
25
26
…
44
Next
Page load link
Go to Top
